Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) ...

Daewoong Pharma's in-house botulinum toxin product Nabota has surpassed 1 trillion won ($665 million) in cumulative sales, ...

The company claims that Dysport is now the first botulinum toxin therapy to demonstrate efficacy in episodic migraine.

Researchers at Stockholm University have succeeded in creating a molecular blueprint of how one of the world's most dangerous toxins, botulinum toxin, is structured, stabilized, delivered and released ...

Seol Hee-soo (49), executive managing director of Hugel's Production and Quality Business Division, expressed this strong ...

The botulinum toxins are among the deadliest substances on Earth, and two specific toxins — including the popular drug Botox — have multiple uses for treating many neuromuscular conditions, including ...

SAN DIEGO — The potential adverse effects of botulinum toxin and fillers aren’t just clinical, a dermatologist warned colleagues. Physicians are at risk of legal consequences if they aren’t careful ...

"Botulinum toxins are not expected to cause death of neurons if they just block signals between neurons and muscles, which is the well-established mode of action for this class of toxins," said Min ...

Over the past 2 decades, the use of botulinum toxin in clinical practice has grown exponentially across all fields of medicine. Initially approved by the US Food and Drug Administration (FDA) in 1989 ...

Seven months after an outbreak of botulism linked to ByHeart infant formula, investigations are still ongoing into how the ...

The toxin behind two outbreaks in seven months is hard to find—and just a handful of labs are equipped to look for it at all ...